Benzbromarone

苯溴马隆

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameBenzbromarone
Drug Alias NamebenzbromaronebenzbromaronabenzbromaronumNarcaricinDesuric +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCytochrome P450 2C9 inhibitors
TargetsCytochrome P450 2C9
Therapy Area/IndicationsHyperuricemiaFamilial Primary Pulmonary HypertensionGout
Global Approved IndicationsGout
Approved Indications in ChinaGout
Original Approved Country/TerritoryMainland China
Original Approved Date1999/01/01
Country/TerritoryAustriaMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesChangzhou Kangpu Pharmaceutical Co Ltd
Inactive CompaniesMedical University Of Graz
Active IndicationsGout
Inactive IndicationsHyperuricemiaFamilial Primary Pulmonary Hypertension

Other Information

ATC CodeM04AB03
Related LinksWikipediaKEGG